Revolution Medicines target price raised to $289 from $246
RVMD•J.P. Morgan raised its target price for Revolution Medicines to $289 from $246.
Related News
Kimball Electronics publishes fiscal Q1 2027 earnings call transcript
KE•
U.S. earnings week ahead
SPY•
Retail investors run for the exit as midterms rattle tech
SPY•
Veeva Systems target price raised to $351 from $283
VEEV•
EOG Resources says it is open to further international pricing exposure as US LNG projects reach FID
EOG•